Add BrightSurf on Google Email

Science News Archive January 2012 - Page 14


Page 14 of 24

Flaky graphene makes reliable chemical sensors

Researchers from the University of Illinois at Urbana-Champaign and Dioxide Materials have developed a chemical sensor using randomly stacked graphene flakes. The thin films of flaky graphene outperformed previous sensors made from carbon nanotubes or graphene crystals, detecting trace amounts of test chemicals with high reliability.

SourceAmerican Institute of Physics·JournalApplied Physics Letters·DateJan 17, 2012

How far is far enough?

Researchers developed a mathematical model to determine safe distances from residential areas for livestock farms, taking into account factors like odor emissions and wind conditions. The model aims to simplify current guidelines and regulations by providing a single, conservative estimate of separation distances.

SourceUniversity of Veterinary Medicine -- Vienna·JournalAtmospheric Environment·DateJan 17, 2012

Arm in plaster changes brain in 16 days

A new study by University of Zurich researchers found that brain areas responsible for the left hand adapt to compensate for an immobile right arm. The study suggests using the undamaged arm to strengthen the affected one through therapy, offering a potential treatment approach for stroke patients.

SourceUniversity of Zurich·JournalNeurology·DateJan 17, 2012

Increasing care needs for children with neurological impairment

A study analyzing hospitalization data in the United States found that children with neurological impairment (NI) account for a significant proportion of inpatient resources. The impact of these children is growing within children's hospitals, necessitating a coordinated approach to ensure their needs are met.

SourcePLOS·JournalPLOS Medicine·DateJan 17, 2012

Rapid diagnosis of severe kidney damage

Researchers identified two biomarkers, NGAL and Kim1, that predict poor outcomes in hospitalization and require dialysis treatment. Early detection of acute kidney injury is crucial to devise an adequate treatment strategy for patients.

SourceHelmholtz Association·JournalJournal of the American College of Cardiology·DateJan 16, 2012

Are you certain, Mr. Heisenberg?

Researchers at Vienna University of Technology distinguish different sources of quantum uncertainty, including fundamental uncertainty rooted in the particle itself. The study confirms the validity of Heisenberg's Uncertainty Principle while revealing a more nuanced understanding of quantum mechanics.

SourceVienna University of Technology·JournalNature Physics·DateJan 16, 2012

'Spooky action at distance' in particle physics?!

Researchers devise a new Bell test to reveal correlations between high-energy particles, shedding light on 'spooky action at distance.' The study's findings have significant implications for understanding particle physics and the link between symmetries and particle correlations.

SourceSpringer·JournalThe European Physical Journal C·DateJan 16, 2012

UH Case Medical Center publishes study on novel treatment for skin lymphoma

Researchers at UH Case Medical Center have discovered a novel treatment approach for cutaneous T-Cell lymphoma, which is a chronic and progressive disease affecting the skin. The new study finds that adding O6-benzylguanine to carmustine enhances topical chemotherapy efficacy, reducing toxicity and improving treatment outcomes.

SourceUniversity Hospitals Cleveland Medical Center·JournalArchives of Dermatology·DateJan 16, 2012

Cancer studies warn over NHS cost-cutting

A leading cancer researcher highlights high levels of doctor-patient trust and confidence within the NHS. Closer clinical relationships between physicians and patients are crucial for coping with treatment and diagnosis. However, cost-cutting measures risk eroding this trust if not carefully implemented.

SourceUniversity of Leicester·JournalClinical Oncology·DateJan 16, 2012

Powerful drug's surprising, simple method could lead to better treatments

Researchers at the University of Illinois have debunked a widely held misconception about an often-prescribed drug, discovering that it works by binding to a lipid molecule essential to yeast's physiology. This finding could lead to better treatments for fungal infections and diseases caused by ion channel deficiencies.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalProceedings of the National Academy of Sciences·DateJan 16, 2012